The University of the Sunshine Coast is a public university based on the Sunshine Coast, Queensland, Australia. After opening with 524 students in 1996 as the Sunshine Coast University College, it was later renamed the University of the Sunshine Coast in 1999.

During the past decade, University of the Sunshine Coast conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of the Sunshine Coast" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of the Sunshine Coast" are "Heart Failure" (2 trials). Many other conditions were trialed in "University of the Sunshine Coast" in a lesser frequency.

Most popular intervention types in "University of the Sunshine Coast" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of the Sunshine Coast" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of the Sunshine Coast". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University of the Sunshine Coast, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of the Sunshine Coast, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".